Results 271 to 280 of about 171,596 (303)

Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials

Lancet, The, 2001
John W. Eikelboom, James D Douketis
exaly  

Total knee replacement

2013
Greg Erens, Thomas Bradbury
openaire   +1 more source

The clinical and cost-effectiveness of total versus partial knee replacement in patients with medial compartment osteoarthritis (TOPKAT): 5-year outcomes of a randomised controlled trial

Lancet, The, 2019
David J Beard, Andrew Price, Seamus Kent
exaly  

Total Knee Replacement

Physiotherapy, 1990
openaire   +1 more source

Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial

Lancet, The, 2002
Bengt I Eriksson
exaly  

Adverse outcomes after total and unicompartmental knee replacement in 101 330 matched patients: a study of data from the National Joint Registry for England and Wales

Lancet, The, 2014
Andrew Judge, Hemant Pandit, David Murray   +2 more
exaly  

Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial

Lancet, The, 2010
Alexander S Gallus, Gary Raskob
exaly  

A Randomized, Controlled Trial of Total Knee Replacement

New England Journal of Medicine, 2015
Søren T. Skou, Ewa M Roos, Mogens B Laursen   +2 more
exaly  

Knee replacement

Lancet, The, 2012
Otto Robertsson, Stephen Graves, Nigel K Arden   +2 more
exaly  

Knee replacement

Lancet, The, 2018
Abtin Alvand, Anders Troelsen, Gary Hooper   +2 more
exaly